0001144204-14-054820.txt : 20140908 0001144204-14-054820.hdr.sgml : 20140908 20140908160238 ACCESSION NUMBER: 0001144204-14-054820 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140829 FILED AS OF DATE: 20140908 DATE AS OF CHANGE: 20140908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua BioMedical, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215-702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 FORMER COMPANY: FORMER CONFORMED NAME: Alliqua, Inc. DATE OF NAME CHANGE: 20101222 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARTON BRADFORD CENTRAL INDEX KEY: 0001618553 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36278 FILM NUMBER: 141091042 MAIL ADDRESS: STREET 1: C/O ALLIQUA BIOMEDICAL, INC. STREET 2: 2150 CABOT BLVD. WEST CITY: LANGHORNE STATE: PA ZIP: 19047 3 1 v388699_3.xml OWNERSHIP DOCUMENT X0206 3 2014-08-29 0 0001054274 Alliqua BioMedical, Inc. ALQA 0001618553 BARTON BRADFORD C/O ALLIQUA BIOMEDICAL, INC. 2150 CABOT BOULEVARD WEST LANGHORNE PA 19047 0 1 0 0 Chief Operating Officer Common Stock 15210 D Stock Option (right to buy) 4.38 2023-05-10 Common Stock 54855 D Stock Option (right to buy) 5.47 2023-05-10 Common Stock 54855 D Stock Option (right to buy) 6.56 2023-05-10 Common Stock 54855 D Stock Option (right to buy) 8.75 2023-05-10 Common Stock 54855 D Stock Option (right to buy) 10.94 2023-05-10 Common Stock 54855 D Stock Option (right to buy) 9.00 2024-03-06 Common Stock 70000 D Warrant (right to buy) 4.24 2013-06-28 2018-06-28 Common Stock 9877 D The number of shares and prices reported in this Form 4 reflect a 1-for-43.75 reverse stock split of the common stock of the Issuer that occurred on November 18, 2013. Represents a single option granted on May 10, 2013 in five separate tranches. Each tranche vests in three equal annual installments, with one-third (1/3rd) vesting on May 10, 2013, May 17, 2014 and May 17, 2015, subject to Mr. Barton's continued service with the Issuer on the applicable vesting date. The option vests in three equal annual installments, with one-third (1/3rd) vesting on March 6, 2015, 2016 and 2017, subject to Mr. Barton's continued service with the Issuer on the applicable vesting date. /s/Bradford Barton 2014-09-08